Wednesday, June 03, 2020 7:41:56 AM
Labsolute wrote on 21.05.20 17:25:37 Entry No. 1.785 (63.763.840) Reply to entry no .: 63.763.585 by tycoon111 am 05/21/20 16:55:36 I am optimistic from the bottom up and may be concerned with my investments, maybe that's the reason And: the burn rate is great, nothing is too high !! Capital increases are also absolutely normal for such companies. Volition has never had any problems getting fresh cash in the past and has always been supported by the state. You can not be blamed for burning the shareholders' money senselessly! And slowly what needs to be monetized is your opinion as so I take on young impatient small shareholders. I see the data that was published a week ago and I know that such a diagnosis no other company in the world can - not at Stage1 and not at the price and time required. And in my opinion it will stay that way for a long time! I do not know whether the price climbs up or down as your question was - but I see a ridiculous market capitalization which can only increase tenfold in the short term (vet / Lung china / COVID) with just one successful piece of the puzzle and on the other hand I see a stable balance sheet a lot of cash and competitors who all still need a lot of time! So an excellent change risk ratio, even if small cap very risky!
Labsolute wrote on 23.05.20 14:18:01 Entry No. 1.789 (63.779.455) no topic - welcome to high risk - high reward. You have to get along with the Vola - especially difficult as an ETF investor. Always think of fear vs greed and rationally rethink everything in difficult phases. We are in a wild market phase: from V-recovery to deepest depression, everything is in the room - if you have already felt uncomfortable, rethink the position size. Otherwise there is now more than enough cash in the company to survive this phase and we can look forward to further data and news this year. Reynolds directly secured a small package for $ 2.75. Think that calms many people again.
https://www.wallstreet-online.de/diskussion/1275261-1781-1790/bluttest-krebserkennung-valitionrx-was
Recent VNRX News
- Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems • PR Newswire (US) • 03/06/2026 01:10:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:32:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:32:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:32:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:31:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:31:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:30:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:30:29 PM
- VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution • PR Newswire (US) • 02/25/2026 01:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 10:15:32 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/20/2026 05:15:15 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/11/2026 10:05:44 PM
- Volition Announces the Appointment of New Distributor for Nu.Q® Discover • PR Newswire (US) • 02/10/2026 01:07:00 PM
- VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards • PR Newswire (US) • 02/09/2026 10:20:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/09/2026 10:16:09 PM
- Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation • PR Newswire (US) • 02/04/2026 01:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:05:05 PM
- VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays • PR Newswire (US) • 01/30/2026 01:50:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
